Primary Site >> Liver Cancer
Gene >> ABCC3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. PMID: 11745434 |
Ref: Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases. PMID: 12428063 |
Ref: Hepatobiliary transporter expression in human hepatocellular carcinoma. PMID: 15780063 |
Ref: Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha. PMID: 16467456 |
Ref: Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety. PMID: 17223971 Ref: The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. PMID: 17982673 |
Ref: Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. PMID: 17991769 Ref: [Detection of multidrug resistance-associated proteins MRP2, MRP3, and MRP5 mRNA expressions in hepatocarcinoma cells using SYBR real-time PCR]. PMID: 18250047 Ref: Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. PMID: 18393293 Ref: Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma. PMID: 18619700 Ref: Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. PMID: 19055643 |
Ref: Mechanisms of resistance of hepatocyte retinoid X receptor alpha-null mice to WY-14,643-induced hepatocyte proliferation and cholestasis. PMID: 19176532 |
Ref: Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. PMID: 20663969 |
Ref: ABC transporters, bile acids, and inflammatory stress in liver cancer. PMID: 21118090 Ref: Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma. PMID: 21480325 |
Ref: Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. PMID: 21932399 Ref: Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys. PMID: 22268002 Ref: Curcumin resistance induced by hypoxia in HepG2 cells is mediated by multidrug-resistance-associated proteins. PMID: 23225435 |
Ref: MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma. PMID: 23320839 Ref: Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma. PMID: 23786867 |
Ref: Coexpression of organic anion-transporting polypeptides 1B3 and multidrug-resistant proteins 2 increases the enhancement effect of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on hepatocellular carcinoma in magnetic resonance imaging. PMID: 23607695 Ref: [Three cases of hepatocellular carcinoma with nodules showing different signal intensities in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI]. PMID: 24806238 |
Ref: Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity. PMID: 25781341 Ref: Analysis of gene expression profiles as a tool to uncover tumor markers of liver cancer progression in a rat model. PMID: 25798242 Ref: Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development. PMID: 25842354 Ref: Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication. PMID: 26160117 Ref: Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma. PMID: 26325606 Ref: Protein kinase C-dependent regulation of human hepatic drug transporter expression. PMID: 26462574 |
Ref: The transmembrane transporter ABCC3 participates in liver cancer progression and is a potential biomarker. PMID: 26337276 Ref: Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials. PMID: 26522694 Ref: MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma. PMID: 26769852 Ref: Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. PMID: 26985715 Ref: Silencing MRP1-4 genes by RNA interference enhances sensitivity of human hepatoma cells to chemotherapy. PMID: 27398162 Ref: Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells. PMID: 28036031 |
Ref: Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells. PMID: 29069816 |
Ref: Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics. PMID: 29138286 Ref: Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma. PMID: 29464551 Ref: Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines. PMID: 29545174 Ref: N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models. PMID: 29850457 |